AIMab-7195
- Generic Name
- AIMab-7195
Safety, Tolerability, and Bioavailability of Subcutaneously Administered XmAb®7195
- First Posted Date
- 2016-08-29
- Last Posted Date
- 2017-07-11
- Lead Sponsor
- Xencor, Inc.
- Target Recruit Count
- 57
- Registration Number
- NCT02881853
- Locations
- 🇺🇸
ICON Early Phase Services, LLC, San Antonio, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath